Vertex Pharmaceuticals Inc / Ma (VRTX) — GAAP EPS actuals & earnings history
As-filed GAAP earnings, announcement timing (BMO/AMC), margins, and Form 4 insider transactions for Vertex Pharmaceuticals Inc / Ma — every data point sourced from SEC EDGAR and auditable to the original filing.
Coverage2009-03 to 2026-06
Quarters70
Earnings quality100.0/100 (tier A)
SourceEDGAR
The quality score grades this ticker’s GAAP EPS series only. Form 4 and other modules use separate coverage checks in the quality report.
Recent GAAP EPS for VRTX
A sample of the most recent as-filed diluted GAAP EPS. The full 2009-03 to 2026-06 history (70 quarters) is included in the Aegwah dataset.
| Fiscal quarter | Diluted EPS (GAAP) | Revenue | Filed | EDGAR |
|---|---|---|---|---|
| 2026Q2 | 4.31 | $3.33B | 2026-08-04 | 0000875320-26-000259 |
| 2026Q1 | 4.02 | $2.99B | 2026-05-05 | 0000875320-26-000173 |
| 2025Q3 | 4.2 | $3.08B | 2025-11-04 | 0000875320-25-000232 |
| 2025Q2 | -13.92 | $2.65B | 2025-08-05 | 0000875320-25-000216 |
| 2025Q1 | 4.21 | $2.69B | 2025-05-06 | 0000875320-25-000192 |
| 2024Q3 | 3.97 | $2.48B | 2024-11-05 | 0000875320-24-000223 |
| 2024Q2 | 3.52 | $2.49B | 2024-08-02 | 0000875320-24-000198 |
| 2024Q1 | 2.69 | $2.37B | 2024-05-07 | 0000875320-24-000139 |
What you get for VRTX
- As-filed diluted & basic GAAP EPS (split-adjusted) for every reported quarter
- Revenue, net income, and gross margin where reported in XBRL
- Announcement timing — before-market (BMO) or after-market (AMC) from matched 8-K acceptance time
- Form 4 insider open-market buys & sells (Pro adds clusters & conviction scores)
- The SEC
edgar_accessionandfiling_urlon every EDGAR-sourced record
Access VRTX data via API
The same membership unlocks a ZIP download and a Bearer-token REST API:
curl -H "Authorization: Bearer <your-key>" \
https://api.aegwah.com/v1/actuals/earnings/VRTX
Get the full VRTX history
All 502 S&P 500 + S&P 400 tickers, 16+ years of GAAP EPS, ZIP + REST API. From $30/month.
View plans →Related: how this data is sourced & scored · per-ticker quality report · VRTX filings on SEC EDGAR